Clinical trialObservationalUnknown
Role of Perfusion CT in Pancreatic Cancer
Evaluation of Diagnostic Efficacy of Perfusion CT Using Wide Detector for Staging and Response Prediction After Chemotherapy in Pancreatic Cancer
- Outcome
- Outcome unknown
- Phase
- Observational
- Status
- Unknown
- Study type
- Observational
- Start
- November 2012
- Listed end
- September 2021
- Enrollment
- 48 participants
- Sites
- 1
- Primary outcomes
- Evaluation of the correlation between the initial perfusion parameters of the tumor and response of the chemotherapy
- Sponsor type
- Academic / other
- Results posted
- No
- Last update
- 8 October 2020
These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
The purpose of this study is 1. to determine whether the perfusion parameters in the normal pancreas and the pancreas cancer (adenocarcinoma or neuroendocrine tumor) are different on perfusion CT 2. to determine whether initial perfusion parameters as well as perfusion parameter change in pancreas adenocarcinoma before and after chemotherapy are different between chemotherapy response group (CR, PR according to RECIST 1.1) and non response group (SD, PD according to RECIST 1.1).
Detailed description public domain (ClinicalTrials.gov)
1. Performance of preoperative perfusion CT for preoperative staging is assessed by comparing with operative finding and histologic disease staging 2. Estimation of initial or change of pancreas cancer perfusion parameters and whether those can provide cut-off value for predicting response of chemotherapy in patients with pancreas adenocarcinoma